Psychologists in Maysville, KY Accepting Medicare

9 Psychologists found. Showing 1 - 9

Jarvis M Brookins, LPCA Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: U.s. 68 Ste 900, Maysville, KY 41056 Phone: 606-584-7055

Nancy Jeanne Vanzile, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 611 Forest Ave, Maysville, KY 41056 Phone: 606-564-4016    Fax: 606-564-4016

Jeffrey A Drury, PHD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 611 Forest Ave, Maysville, KY 41056 Phone: 606-564-4016    Fax: 606-564-8288

Janice W George, M.A. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 611 Forest Ave, Maysville, KY 41056 Phone: 606-564-4016    Fax: 606-564-8288

Megan Howell, MA Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 611 Forest Ave, Maysville, KY 41056 Phone: 606-564-4016    Fax: 606-564-8288

Mrs. Barbara Kay Jefferson, PHD Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 611 Forest Avenue, Maysville, KY 41056 Phone: 606-564-4016    Fax: 606-564-8288

Dr. Phyllis Raye Biddle, PH.D. Psychologist - Counseling Medicare: Not Enrolled in Medicare Practice Location: 611 Forest Ave, Maysville, KY 41056 Phone: 606-564-4016    Fax: 606-564-0295

Martin W George, MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 611 Forest Ave, Maysville, KY 41056 Phone: 606-564-4016    Fax: 606-564-8288

Amanda Johnson Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 611 Forest Ave, Maysville, KY 41056 Phone: 606-564-4016    Fax: 606-564-8288

News Archive

New data shows abemaciclib continues to benefit high-risk, HR+, HER2-, early-stage breast cancer patients

Extended follow-up data from the phase III monarchE trial showed that adding the cyclin-dependent kinase (CDK) inhibitor abemaciclib (Verzenio) to standard adjuvant endocrine therapy continued to improve invasive disease-free survival (IDFS) among patients with high-risk, node-positive, early-stage, HR-positive, HER2-negative breast cancer, according to data presented at the 2020 San Antonio Breast Cancer Symposium, held Dec. 8-11.

Hi-tech initiative aims to help doctors treat brain tumours

Software that gives doctors much-needed help in the diagnosis and treatment of brain tumours is being developed by an international consortium of scientists and medics.

Researchers identify protein that plays critical role in cancer treatment-related heart damage

Many cancers can be successfully treated, but treatment itself often comes with risks as well. Cancer therapy that uses anthracyclines-a class of commonly used chemotherapy drugs-has been associated with heart damage that can eventually result in heart failure. It is thought to be the reason why heart disease is a leading cause of death in cancer survivors, immediately following cancer recurrence.

Scientist receives $1.7 million grant to study how early life toxic exposures predispose to diabetes

Some studies indicate that early life exposure to pollutants such as PCBs and phthalates can predispose people to disease. Now environmental scientist Alicia Timme-Laragy at the University of Massachusetts Amherst has received a five-year, $1.7 million grant from the National Institute of Environmental Health Sciences for a multi-level study of early life exposure to environmental contaminants and aberrant pancreas development, which may predispose one to diabetes.

Investigational mRNA vaccine to prevent SARS-CoV-2 shows promise in older adults

A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults.

Read more Medical News

› Verified 6 days ago